Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Endoglin antibody (FITC)

This Mouse Monoclonal antibody specifically detects Endoglin in FACS. It exhibits reactivity toward Human.
Catalog No. ABIN641446

Quick Overview for Endoglin antibody (FITC) (ABIN641446)

Target

See all Endoglin (ENG) Antibodies
Endoglin (ENG)

Reactivity

  • 231
  • 71
  • 70
  • 21
  • 17
  • 16
  • 15
  • 3
  • 3
  • 3
  • 1
  • 1
Human

Host

  • 146
  • 116
  • 20
  • 2
  • 1
  • 1
Mouse

Clonality

  • 163
  • 122
  • 1
Monoclonal

Conjugate

  • 115
  • 29
  • 28
  • 23
  • 18
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Endoglin antibody is conjugated to FITC

Application

  • 165
  • 164
  • 93
  • 55
  • 37
  • 35
  • 27
  • 25
  • 25
  • 18
  • 13
  • 10
  • 7
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)
  • Purpose

    Mouse Anti-Human CD105 [+FITC]

    Specificity

    DS-MB-00245 recognises the human CD105 cell surface antigen, a glycoprotein homodimer of 95kD subunits. CD105 is also known as endoglin, and is expressed by endothelial cells, activated monocytes and some leukaemia cells.

    Cross-Reactivity

    Horse (Equine)

    Characteristics

    Adhesion Molecule/Cell Surface

    Immunogen

    Partially purified cell membrane antigens from fresh leukaemia cells.

    Isotype

    IgG1
  • Application Notes

    Flow Cytometry

    Restrictions

    For Research Use only
  • Concentration

    IgG concentration 0.1 mg/ml

    Buffer

    Phosphate buffered saline

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    Endoglin (ENG)

    Alternative Name

    CD105
You are here:
Chat with us!